Orchestra BioMed Holdings, Inc. (OBIO): Capital Expenditures

Annual figures by period end, from SEC filings.

$489.0K
Year ended 2025-12-31
$781.0K
Trailing 12 months to 2026-06-30
-6.1%
3-year compound annual growth
$591.0K2022-12-31: $591.0K2023-12-31: $78.0K2024-12-31: $289.0K2025-12-31: $489.0K$489.0K
2022-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$489.0K+69.2%2026-03-12, From 2025-01-01
2024-12-31$289.0K+270.5%2026-03-12, From 2024-01-01
2023-12-31$78.0K-86.8%2025-03-31, From 2023-01-01
2022-12-31$591.0Kn/a2024-03-27, From 2022-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Orchestra BioMed Holdings, Inc. (OBIO)2025-12-31$489.0K+69.2%
Premier Air Charter Holdings Inc. (PREM)2025-12-31$2.55M+70.8%
ClearPoint Neuro, Inc. (CLPT)2025-12-31$522.0K+89.8%
Cytosorbents Corp (CTSO)2025-12-31$164.0K-42.3%
Retractable Technologies Inc (RVP)2024-12-31$1.44M+68.8%
Utah Medical Products Inc (UTMD)2025-12-31$371.0K+61.3%
Interpace Biosciences, Inc. (IDXG)2025-12-31$356.0K-59.4%
Sensus Healthcare, Inc. (SRTS)2025-12-31$196.0K-29.0%
KORU Medical Systems, Inc. (KRMD)2025-12-31$932.5K-28.1%

Compare OBIO, PREM, CLPT, CTSO side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗